Immunogenicity of SARS-CoV-2 vaccination in adolescents with cardiac disease.

Hiroki HayashiJun Narita Ryo IshiiMasaki HiroseKazuhisa HashimotoYoshiaki YamagishiKeiichi OzonoHironori NakagamiHidekazu Ishida

Published in: Pediatrics international : official journal of the Japan Pediatric Society (2022)

SARS-CoV-2 mRNA vaccine has efficient immunogenicity for adolescents with CHD, IPAH, and DCM. Half of post-HTx patients could not acquire sufficient humoral immunity.

Keyphrases

sars cov
young adults
end stage renal disease
physical activity
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
heart failure
patient reported outcomes